Budge James 4

What Happened
Budge James, Chief Financial Officer of Hinge Health, received an award of 65,000 restricted stock units (RSUs) on April 29, 2026. The RSUs were reported at $0.00 per unit (no cash paid at grant), so the transaction value on the Form 4 is $0. This is an equity compensation grant (award), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-29 (Grant/Award, code A)
• Report filed with SEC: 2026-05-19 (Form 4 accession 0001338176-26-000018) — filing appears later than the standard 2-business-day Form 4 window.
• Shares/units granted: 65,000 RSUs @ $0.00 (reported value $0)
• Shares owned after transaction: Not reported in the filing.
• Footnote: RSUs were acquired through an exempt transaction with the issuer; each RSU represents a right to receive one share of Class A common stock at vesting for no consideration.

Context
RSU grants are a common form of executive compensation; they vest over time or upon achievement of conditions and do not require immediate cash outlay. Because these are awards rather than purchases or sales, they do not directly signal a bullish or bearish trading decision by the insider. The late filing may affect timeliness of disclosure but does not change the nature of the grant.